超性心肌病中的CMR衍生的应变和扭曲揭示亚临床功能障碍:前性病例对照研究
Alexandru Zlibut1,2, Ioana Danuta Muresan1, Michael Bietenbeck2
1Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Biomedicines
|August 28, 2025
概括
心磁共振 (CMR) 的特征追踪在肌肉缩性心肌病 (HCM) 患者中发现了早期心肌功能障碍,甚至在纤维化明显之前. 全球左心室扭曲是检测这种功能障碍和预测预后的高度敏感标志物.
科学领域:
- 心脏病学
- 医学成像
- 生物物理
背景情况:
- 缩性心肌病 (HCM) 常常呈现出保留的排泄分数,掩盖了亚临床心肌功能障碍.
- 传统的成像技术可能无法检测HCM心脏机制受损的早期迹象.
- 具有特征追踪 (FT) 的心磁共振 (CMR) 提供了评估心肌变形的先进功能.
研究的目的:
- 评估CMR衍生的应变和扭曲参数在早期发现心肌功能障碍患者中的有用性.
- 将FT-CMR指标的诊断性能与已知的心肌纤维化标志物进行比较.
- 调查 HCM 全球左心室扭曲的预后价值.
主要方法:
- 一项前性病例对照研究,涉及150名HCM患者和100名健康对照.
- 使用标准化CMR协议通过FT-CMR量化全球纵向应变 (GLS),周围应变 (GCS),辐射应变 (GRS) 和LV扭曲.
- 使用晚期加多增强 (LGE),原生T1映射和细胞外体积 (ECV) 来评估心肌纤维化.
主要成果:
- 与对照组相比,HCM患者的GLS,GCS,GRS和LV扭曲显著受损 (p < 0. 001).
- 这些功能异常甚至存在于LGE阴性HCM患者中,表明早期重塑.
- 与GLS,T1映射和ECV相比,LGE检测的全球LV扭曲显示出更高的诊断性能 (AUC=0. 995).
结论:
- 由CMR衍生的应变和扭转参数有效地检测HCM的亚临床心肌功能障碍.
- 全球 LV 扭曲是一种敏感且强大的非侵入性标志物,在 HCM 中具有显著的诊断和预后潜力.
- 这些发现突显了高级CMR技术在了解HCM病理生理学和患者结果方面的价值.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy IV: Restrictive Cardiomyopathy
27
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
27
Cardiomyopathy I: Introduction and Classification
50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21


